BioAtla, Inc. (BCAB)
NASDAQ·Healthcare·Biotechnology
$1.69
—
Mkt Cap $5.31M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$250.00
Range $250.00 – $250.00
Implied Upside
+14692.9%
Consensus $250.00 vs current $1.69
NASDAQ·Healthcare·Biotechnology
$1.69
—
Mkt Cap $5.31M
No recent rating data.
Price Target (1 analysts)
$250.00
Range $250.00 – $250.00
+14692.9%
Consensus $250.00 vs current $1.69